The Journal of Practical Medicine ›› 2025, Vol. 41 ›› Issue (14): 2250-2257.doi: 10.3969/j.issn.1006-5725.2025.14.019

• Drugs and Clinic Practice • Previous Articles    

Effects of different dose dexmedetomidine combined with sufentanil on perioperative analgesia and sleep quality in patients with oral cancer

Xiaomei BAO,Yu LIU,Chengcheng JIN,Luping. WANG()   

  1. Department of Anesthesiology,Stomatological Hospital of Jilin University,Changchun 130012,Jilin,China
  • Received:2025-04-07 Online:2025-07-25 Published:2025-07-29
  • Contact: Luping. WANG E-mail:bxm5639@163.com

Abstract:

Objective To investigate the effect of high, middle and low dose dexmedetomidine combined with sufentanil on perioperative analgesia and sleep quality in patients with oral cancer. Methods A total of 158 patients undergoing oral cancer surgery in the hospital from January 2023 to June 2024 were selected and divided into group A[n = 53,0.6 μg/(kg·h) dexmedetomidine + 2 μg/kg sufentanil]and group B[n = 53,0.4 μg/(kg·h) dexmedetomidine + 2 μg/kg sufentanil] , Group C [n = 52, 0.2 μg/(kg·h) dexmedetomidine + 2 μg/kg sufentanil]by random number table method. Stress response indexes [brain-derived neurotrophic factor (BDNF), cortisol (Cor), interleukin-6 (IL-6)], bifrequency index and analgcsia nociccption index(BIS, ANI), pain level, T lymphocyte subsets CD3+, CD4+, CD8+ levels, Richards Campbell Sleep Scale (RCSQ) score and adverse reactions were compared between the two groups. Results Compared with 12 h before surgery, serum levels of BDNF, Cor and IL-6 in 3 groups were decreased 48 h after surgery, group A was lower than group B, group C, group B was lower than group C(P < 0.05). Compared with T0, BIS at T1 ~ T3 were significantly different between the 3 groups (P < 0.05), BIS at T1 ~ T3 were lower than those at T0P < 0.05), and there was no significant difference in BIS at the same time between the 3 groups (P>0.05), from T1 to T3, ANI was higher than that at T0, and ANI in group A was higher than that in group B and group C (P < 0.05). Compared with the preoperative results, the pain scores of the 3 groups were decreased at 1 h, 6 h, 24 h and 48 h after operation, and the pain scores of group A were lower than those of group B and C, and the pain scores of group B were lower than those of group C (P < 0.05). After operation, CD3+ and CD4+ were decreased in all 3 groups, group A was lower than group B and group C, group B was lower than group C (P < 0.05), and CD8+ was increased in all 3 groups, group A was higher than group B and group C, group B was higher than group C (P < 0.05). Compared with 1 day before the operation, the sleep quality scores of the three groups on the night after the operation and the second night after the operation were all decreased, group A was lower than group B and group C, and group B was lower than group C(P < 0.05). The incidence of hypotension and sinus bradycardia in group A was higher than that in group B and group C (P < 0.05). There was no significant difference in the incidence of hypotension and sinus bradycardia between group B and group C (P > 0.05). There was no significant difference in the incidence of nausea, vomiting and dizziness among the three groups (P > 0.05). Conclusion The analgesic effect of 0.6 μg/(kg·h) dose dexmedetomidine combined with sufentanil can effectively reduce the body's stress response and immune suppression, improve sleep quality, but with a greater incidence of intraoperative hypotension and bradycardia.

Key words: oral cancer, dexmedetomidine, sufentanil, different doses, analgesia, sleep quality

CLC Number: